MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$19,864K
EPS
-$0.59
Unit: Thousand (K) dollars

Income Statement
2026-06-30
2026-03-31
2025-12-31
Research and development
10,942 8,542 7,296*
General and administrative
11,025 6,867 3,067*
Total operating expenses
21,967 15,409 10,362
Loss from operations
-21,967 -15,409 -10,362*
Interest income
2,103 1,591 777*
Change in fair value of redeemable convertible preferred stock tranche liability
0 0 382*
Total other income (expense)
2,103 1,591 395*
Loss before income tax
-19,864 -13,818 -9,967*
Federal
--0*
State
--0*
Foreign
--0*
Total current taxes
--0*
Federal
--2,177*
State
--302*
Foreign
--0*
Total deferred taxes
--2,478*
Valuation allowance
---2,477*
Income tax provision
0 0 0*
Net loss
-19,864 -13,818 -9,967
Basic EPS
-0.59 -0.69 -4.496
Diluted EPS
-0.59 -0.69 -4.496
Basic Average Shares
33,439,543 19,927,848 2,217,104
Diluted Average Shares
33,439,543 19,927,848 2,217,104
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$19,864K Interest income$2,103K Loss before incometax-$19,864K Total other income(expense)$2,103K Loss from operations-$21,967K Total operatingexpenses$21,967K General andadministrative$11,025K Research and development$10,942K

SpyGlass Pharma, Inc. (SGP)

SpyGlass Pharma, Inc. (SGP)